Skip to content
Open Data Finder
Open Government Canada

Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)

Published by Health Canada | Santé Canada

About this dataset

This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA.

Guidance Document - Pharmaceutical Development ICH Topic Q8(R2) · Open Data Finder